Status
Conditions
Treatments
About
Dietary strategies for alleviating health complications associated with type 2 diabetes (T2D) are being pursued as alternatives to pharmaceutical interventions. Berries such as blackcurrants that are rich in polyphenols may influence carbohydrate digestion and absorption and thus postprandial glycaemia. In addition berries have been reported to alter incretins as well as to have anti-oxidant and anti-inflammatory properties that may also affect postprandial glycaemia. This study investigated the acute affect blackcurrants on glucose metabolism in overweight/obese volunteers .
Full description
Sixteen overweight/obese volunteers from the Aberdeen area will be recruited into a randomised controlled study. Volunteers will be randomised into four groups matched for BMI and age and given 200 grams of blackcurrants (which contain anthocyanins) or greencurrants (which naturally contain no anthocyanins), followed by an OGTT.
The consumption of the currants will be followed by an oral glucose tolerance test (OGTT) with Polycal (complex carbohydrate) or glucose (simple carbohydrate) as the carbohydrate load.
There will be a one week minimum wash out period between each intervention. All interventions will be randomised and blinded as far as possible in a cross-over design where the volunteers are acting as their own control. The volunteers will be asked to consume a low phytochemical diet three days prior to taking the currants all occasions. In addition, they will be asked to record what they ate over the same period in a simple food diary.
The following intervention will be carried out on 16 overweight/obese male/postmenopausal female non-smoker volunteers:
Note: the polycal will contain the equivalent glucose load as given in intervention 3 assuming complete hydrolysis of all carbohydrates.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Medical exclusion criteria
Chronic illness, including:
Alcohol or any other substance abuse
Eating disorders
Psychiatric disorders (including severe depression, lithium treatment, schizophrenia, severe behavioural disorders)
Non-postmenopausal women
Medication exclusion criteria
Oral steroids
Tricyclic antidepressants, neuroleptics
Anticoagulants
Digoxin and anti-arrhythmics
Chronic use of anti-inflammatories (e.g. high doses of aspirin, ibuprofen), Insulin, -Sulphonylureas, Thiazolidinediones (glitazones), metformin.
Anti-obesity medication e.g. Orlistat
Primary purpose
Allocation
Interventional model
Masking
16 participants in 4 patient groups
Loading...
Central trial contact
Nigel Hoggard, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal